| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 14 |
| 1 | ASPIRIN 325 MG | 14 |
| 2 | ASPIRIN 81 MG | 14 |
| 3 | ROSUVASTATIN | 13 |
| 4 | RIBOCICLIB | 5 |
| 5 | FULVESTRANT | 4 |
| 6 | ACETAMINOPHEN | 3 |
| 7 | ERGOCALCIFEROL | 3 |
| 8 | LISINOPRIL | 3 |
| 9 | METFORMIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIZATIDINE | 1 | 0.0007 |
| 1 | LIDOCAINE HCL | 1 | 0.0004 |
| 2 | LOMITAPIDE MESYLATE | 1 | 0.0003 |
| 3 | LOXAPINE | 1 | 0.0003 |
| 4 | FERRIC CARBOXYMALTOSE | 1 | 0.0002 |
| 5 | RIBOCICLIB | 5 | 0.0002 |
| 6 | ROSUVASTATIN | 13 | 0.0002 |
| 7 | OFLOXACIN | 1 | 0.0001 |
| 8 | FULVESTRANT | 4 | 0.0001 |
| 9 | INCLISIRAN | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 11 |
| 3 | Estrogen Receptor Antagonist [EPC] | 4 |
| 4 | Antiarrhythmic [EPC] | 3 |
| 5 | Expectorant [EPC] | 3 |
| 6 | Provitamin D2 Compound [EPC] | 3 |
| 7 | Vitamin C [EPC] | 3 |
| 8 | Amide Local Anesthetic [EPC] | 2 |
| 9 | Atypical Antipsychotic [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Vitamin K [EPC] | 1 | 0.0001 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 5 | Estrogen Receptor Antagonist [EPC] | 4 | 0.0001 |
| 6 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 2 | 0.0000 |
| 9 | Leukotriene Receptor Antagonist [EPC] | 1 | 0.0000 |